EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bortezomib Is Effective in the Treatment of T Lymphoblastic Leukaemia by Inducing DNA Damage, WEE1 Downregulation, and Mitotic Catastrophe

Rahman Ud Din iD, Anan Jiao, Yinxia Qiu, Aarmann Anil Mohinani Mohan, Kei-Ching Yuen, Hoi-Tung Wong, Timothy Ming-Hun Wan iD, Phoebe On-Yi Wong, Chun-Fung Sin

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241914646 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Rahman Ud Din und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Queen Mary Hospital, The University of Hong Kong, 102 Pokfulam Road, Hong Kong, China. Hauptthemen laut MEDLINE: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Antineoplastic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Hong Kong, Health and Medical Research Fund of Health Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T lymphoblastic leukemia (T-ALL) is an aggressive haematolymphoid malignancy comprising 15% of acute lymphoblastic leukemia (ALL). Although its prognosis has improved with intensive chemotherapy, the relapse/refractory disease still carries a dismal prognosis. Thus, there is an urgent need to develop novel therapy for T-ALL. Bortezomib, a 26S proteasome inhibitor, is licensed to treat plasma cell myeloma and mantle cell lymphoma. Due to its favorable side effect profile, it is a novel agent of research interest in the treatment of ALL. Despite an increasing number of clinical trials of bortezomib in T-ALL, its detailed mechanistic study in terms of DNA damage, cell cycle, and mitotic catastrophe remains elusive. Moreover, WEE1, a protein kinase overexpressed in ALL and involved in cell-cycle regulation, has been known to be a novel therapeutic target in many cancers. But the role of bortezomib in modulating WEE1 expression in ALL still remains elusive. In this study, we demonstrate the therapeutic efficacy of bortezomib on T-ALL primary samples and cell lines. Our findings reveal that bortezomib treatment induces DNA damage and downregulates WEE1, leading to G2-M cell-cycle progression with damaged DNA. This abnormal mitotic entry induced by bortezomib leads to mitotic catastrophe in T-ALL. In conclusion, our findings dissect the mechanism of action of bortezomib and provide further insights into the use of bortezomib to treat T-ALL. Our findings suggest the possibility of novel combination therapy using proteasome inhibitors together with DNA-damaging agents in the future, which may fill the research gaps and unmet clinical needs in treating ALL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor T-Cell Lymphoblastic Leukemia-LymphomaLymphoma, Non-HodgkinPrecursor Cell Lymphoblastic Leukemia-LymphomaAntineoplastic AgentsHumansAdultBortezomibDown-RegulationProteasome InhibitorsDNA DamageDNACell Line, TumorProtein-Tyrosine KinasesCell Cycle Proteins

Stichwörter der Autor:innen

DNA damageWEE1acute lymphoblastic leukemiabortezomibmitotic catastropheproteasome inhibitors

Substanzen

BortezomibProteasome InhibitorsDNAAntineoplastic AgentsWEE1 protein, humanProtein-Tyrosine KinasesCell Cycle Proteins

Autor:innen und Institutionen

  • Department of Pathology, Queen Mary Hospital, The University of Hong Kong, 102 Pokfulam Road, Hong Kong, China.

ORCID-Profile: Rahman Ud Din, Timothy Ming-Hun Wan

Förderung

  • University of Hong Kong
  • Health and Medical Research Fund of Health Bureau

Zitieren

APA

Din, R. U., Jiao, A., Qiu, Y., Mohan, A. A. M., Yuen, K. C., Wong, H. T., Wan, T. M., Wong, P. O., & Sin, C. F. (2023). Bortezomib Is Effective in the Treatment of T Lymphoblastic Leukaemia by Inducing DNA Damage, WEE1 Downregulation, and Mitotic Catastrophe. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241914646

Vancouver

Din RU, Jiao A, Qiu Y, Mohan AAM, Yuen KC, Wong HT, et al. Bortezomib Is Effective in the Treatment of T Lymphoblastic Leukaemia by Inducing DNA Damage, WEE1 Downregulation, and Mitotic Catastrophe. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241914646

BibTeX
@article{Din2023,
  author = {Din, Rahman Ud and Jiao, Anan and Qiu, Yinxia and Mohan, Aarmann Anil Mohinani and Yuen, Kei-Ching and Wong, Hoi-Tung and Wan, Timothy Ming-Hun and Wong, Phoebe On-Yi and Sin, Chun-Fung},
  title = {Bortezomib Is Effective in the Treatment of T Lymphoblastic Leukaemia by Inducing DNA Damage, WEE1 Downregulation, and Mitotic Catastrophe},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241914646}
}
Kostenlos starten →